Marilyn L. Moy MD
Adjunct Assistant Professor, Pulmonary, Allergy, Sleep & Critical Care Medicine
72 E. Concord Street marilyn.moy@va.gov
Sections
Pulmonary, Allergy, Sleep & Critical Care Medicine
Biography
Marilyn L. Moy, M.D., M.Sc., Associate Professor of Medicine, Harvard Medical School, is a Staff Pulmonary Physician at VA Boston Healthcare System. She is Medical Director of the Pulmonary Rehabilitation Program, accredited by the American Association of Cardiovascular and Pulmonary Rehabilitation. Dr. Moy studies the role of physical activity (PA) in the risk stratification of COPD, technology-based interventions to promote PA, and the biological mechanisms underlying the beneficial effects of PA on COPD outcomes. Her work has contributed to the field of telehealth medicine.
Dr. Moy is internationally recognized as an expert in Pulmonary Rehabilitation. She was the 2016-2017 Chair of the Program Committee of the Rehabilitation Assembly of the American Thoracic Society. She has been an invited speaker at the European Respiratory Congress in Munich, Germany and Amsterdam, Holland. She serves on the Research Advocacy Committee of the ATS.
As the Principal Investigator on VA and NIH funded grants, Dr. Moy published one of the first papers demonstrating that low PA is associated with increased risk for acute exacerbations in COPD. Dr. Moy has developed a novel internet-mediated, pedometer based intervention to promote PA in COPD. Her work was recognized with the 2017 Massachusetts Pulmonary Section award for best clinical research abstract. Dr. Moy also examines biological mechanisms including the relationship between PA and telomere length, and the epigenetic changes associated with improvements in PA. Dr. Moy is VA Boston's 2017 nominee for the Presidential Early Career Award for Scientists and Engineers.
Dr. Moy is a Co-Investigator for a pragmatic trial examining a PA coaching intervention (PCORI), and a trial on the efficacy of Tai Chi to maintain benefits after conventional pulmonary rehabilitation in COPD (NIH-NCCIH). Dr. Moy has been the site-PI for NHLBI clinical trials.
Education
Medicine, MD, Harvard Medical School
Epidemiology, MSc, Harvard School of Public Health
Biology, AB, Radcliffe College
Publications
Leonhard AG, Coggeshall S, Gleason E, Collins M, Barjaktarevic I, Bascom R, Bon J, Comellas AP, Diaz PT, Hanania NA, Han MK, Hansel NN, Hee Wai T, Krishnan JA, Lazarus SC, Ma J, Maddipati V, Mador MJ, Make BJ, McEvoy CE, Meldrum C, Millard MW, Moy ML, Pirozzi CS, Plumley R, Que LG, Reed RM, Sciurba FC, Sethi S, Simonelli PF, Sumino K, Tiwari A, Voelker K, Wendt CH, Wisniewski SR, Au DH, Donovan LM, Feemster LC. Effect of a self-directed lifestyle-based weight management program among patients with comorbid COPD and sleep apnea: a secondary analysis of the INSIGHT COPD trial. Ann Am Thorac Soc. 2026 Mar 01; 23(3):419-428. PMID: 41135051.
Published on 1/12/2026Eggert LE, Moy ML. Doing More With Less: Lessons From a Safety-Net Hospital Community-Based Pulmonary Rehabilitation Program. Respir Care. 2026 Feb; 71(2):237-239. PMID: 41626653.
Published on 10/28/2025Kraemer KM, Litrownik D, Wayne PM, Richardson CR, Bhomia N, Kadri R, Rist PM, Ngo L, Moy ML, Yeh GY. Promoting Walking in Cardiopulmonary Disease With Mindful Steps: Pilot Feasibility Randomized Controlled Trial of a Web-Based, Pedometer-Mediated Mind-Body Intervention. JMIR Form Res. 2025 Oct 28; 9:e74118. PMID: 41147625.
Published on 10/1/2025Moy ML, Casaburi R, Garvey C, Bhatt SP, Nici L. The Rapid Evolution of Remotely Delivered Pulmonary Rehabilitation in the United States: Why It Matters to Clarify Terminology Now. Ann Am Thorac Soc. 2025 Oct; 22(10):1453-1456. PMID: 40680219.
Published on 9/1/2025Moy ML, Nici L. An Alarming Loss of Pulmonary Rehabilitation Programs: Example from the U.S. Veterans Administration. Am J Respir Crit Care Med. 2025 Sep; 211(9):1559-1561. PMID: 40505147.
Published on 8/1/2025Moy ML, Corn J, Kizziar A, Kaye R, Dorney Koppel GA, Bhatt SP, Casaburi R, Desiato JT, Garvey C. Characteristics of Virtual Pulmonary Rehabilitation Programs in the United States: Results from a National Electronic Survey. Ann Am Thorac Soc. 2025 Aug; 22(8):1140-1146. PMID: 40036795.
Published on 7/18/2025Bamonti PM, Moy ML, Rose GA, Silberbogen AK, Cully JA, Checko ER, Coultas D, Schell BR, Moye J. Integration of a Pedometer-Based Physical Activity Intervention with Cognitive Behavioral Therapy for Adults with Chronic Obstructive Lung Disease. Cogn Behav Pract. 2025 Jul 18; 2025. PMID: 41424645.
Published on 7/1/2025Bamonti PM, Wingood M, Robinson SA, Rose GA, Moy ML. Psychometric evaluation of the exercise self-regulatory efficacy scale using objective measures of physical functioning in persons with chronic obstructive pulmonary disease. Respir Med. 2025 Sep; 246:108228. PMID: 40609704.
Published on 6/1/2025Wan ES, Decherd J, Stella C, Venne JR, McKeon B, Robinson SA, Bamonti P, Moy ML. Safety and Feasibility of a Two-Way Audiovisual Teleconferenced Pulmonary Rehabilitation Program. CHEST Pulm. 2025 Jun; 3(2). PMID: 41425140.
Published on 5/1/2025Moy ML, Bhatt SP, Casaburi R, Garvey C, Nici L. Not All Tele-Pulmonary Rehabilitation Models for Chronic Respiratory Disease Are Created Equal. Chest. 2025 May; 167(5):e169-e170. PMID: 40348522.